InvestorsHub Logo

nidan7500

04/04/21 4:56 PM

#305848 RE: baltimorebullet #305845

bb

I think there's also considerable career risk for any CEO who would want to go after almost unknown Anavex with it's almost unknown MOA.

But as you say, things are changing.



Yup, the dynamic challenges here (both technology and leadership) are not for the weak hearted. Dropping a massive amount of cash into a deep dark hole ain't easy. So, let's see if the FDA steps up and does it's job....do a BTD call so we can all move on.

IMO, they SHOULD MAKE AN EARLY CALL. The dynamics and possible linked medical consequences are mind blowing. IMO.